Demystifying Medicine 2019
Tuesdays: January 8 through May 7
4:00pm - 5:30pm
Building 50 / Conference Room 1227
(unless otherwise noted)
January 8 - Emerging and Re-emerging Infectious Diseases: A Perpetual Challenge & The Next Influenza Pandemic
The New England Journal of Medicine - Perspective: Influenza Cataclysm, 1918
January 15 - Sepsis and the NIH Critical Care Center
NIH Science Education - Sepsis
Intensive care units, such as that in the NIH Clinical enter, treat such patients, study mechanisms of sepsis and develop improved treatment (and prevention).
January 22 - Tuberculosis: The Great White Plague Keeps Coming Back
Tuberculosis is one of the top 10 causes of death globally and the leading killer of people with HIV. Once thought to be under our control, the ancient plague has staged a global resurgence with worrisome strains of multidrug-resistant TB. In 2017, 10 million people fell ill with TB, and 1.6 million died from the disease, many as a result of these new strains, according to the World Health Organization.
For this next lecture in the Demystifying Medicine series, we bring you to the two frontlines of the TB battle. Ray Chen is a staff clinician in the NIAID Tuberculosis Research Section (TBRS). From 2004 to 2012, Chen was stationed in China administering NIAID's research and intervention projects for TB as well as HIV and influenza. China has an estimated one million new cases of TB every year. With help from NIAID, WHO, and China authorities, Chen witnessed a drop in the prevalence rate by 4.7% per year over the first decade of the 21st century. Nevertheless, the WHO estimates that there are 63,000 new multidrug-resistant TB infections annually in China, and much more work needs to be done.
Meanwhile, back at the NIH, NIAID TBRS Chief Clifton Barry commands a multidisciplinary group of research scientists comprising biologists, chemists, and clinical researchers in a race for therapeutics, diagnostic tools, and TB prevention strategies. Barry's lab has made remarkable strides in understanding the mechanism of action of anti-TB agents. His TBRS has the distinction of being the most highly cited research group in the world in the field of TB over the last 10 years.
Come and learn from the best and, as always, be prepared to be dazzled and demystified.
January 29 - Fungus Infections: Neglected, Dangerous and Increasing
February 5 - Exploring Deep Sea Eco Systems and Human Disease
February 12 - Hepatocellular Cancer: Progress in a Devastating Disease
February 19 - Mount Everest and K2: Too Little and Too Much Oxygen
February 26 - Immunotherapy of Cancer
March 5 - The Case for Reason, Science, Humanism, and Progress
March 12 - Machine Learning and Artificial Intelligence in Radiology
March 19 - Inheritable Cancer
March 26 - Losing and Regaining Hearing: From Humans to Zebrafish
April 2 - Perception and Mis-perception in the Nervous System
April 9 - Global Challenges in Infection with HIV and other Viruses
April 16 - Cardiovascular Failure and Regeneration
April 23 - Autoimmunity: Basic and Clinical Advances and Challenges
May 7 - Futures for PhDs
For questions about the course, please contact firstname.lastname@example.org.
This web page was last modified on 17 January 2019.